The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)—Evaluating the impact of myocardial infarction on patient outcomes
To access this article, please choose from the options below
This study was principally supported by CV Therapeutics, Inc, Palo Alto, CA, and R-01 HS11282-01 from the Agency for Healthcare Research and Quality, Rockville, MD. This study was also supported by a Veterans Affairs Health Services Research Advanced Research Career Development Award (ARCD-98-341-2) (Dr Rumsfeld), Washington, DC.
PII: S0002-8703(05)00529-6
doi:10.1016/j.ahj.2005.05.026
© 2006 Mosby, Inc. All rights reserved.
